Plain-English translation of NCT06190158 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Type 2 Diabetes research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This research study is investigating whether some people with type 2 diabetes have a hidden hormonal condition called primary aldosteronism โ where the body produces too much of a hormone called aldosterone that can damage the kidneys. The study will test whether identifying this condition early could help prevent kidney disease from developing or getting worse in people at risk.
Kidney disease is very common in people with diabetes and can lead to serious heart problems and the need for dialysis. Recent research suggests that this hidden hormone imbalance may be a key reason why some people develop kidney disease, but it often goes undiagnosed. This study exists to find out if we can catch this condition early and use existing, safe medications to prevent kidney damage before it becomes severe.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
As a participant, you would visit the research clinic for several appointments where researchers would perform blood tests, urine tests, and blood pressure checks to look for signs of the hormone imbalance. You may need to temporarily adjust certain blood pressure medications as directed by the study doctors. The study involves screening visits and follow-up visits to monitor how your kidneys are doing and whether the hidden hormone condition is present.
AI-generated summary from trial data ยท Jun 24, 2026 ยท Not medical advice
United States